Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of single and repeat doses of PC945 in subjects with Aspergillosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis

Drugs mentioned

• PC945

Snippet

Sponsor: Pulmocide Ltd | Conditions: Aspergillosis | Phase 1 | Status: COMPLETED